Controlled study of verapamil for treatment of panic disorder.
The authors conducted a 16-week double-blind, crossover study in 11 patients with panic disorder to study the effects of verapamil, a calcium channel blocker commonly used in the treatment of cardiovascular disorders, on the treatment of panic disorder. Their findings suggest that verapamil has modest antianxiety and antipanic properties.
D000328:Adult; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005239:Fear / Q000187:drug effects; D005260:Female; D006801:Humans; D007473:Ion Channels / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010200:Panic / Q000187:drug effects; D010555:Personality Inventory; D011569:Psychiatric Status Rating Scales; D014700:Verapamil / Q000494:pharmacology / Q000627:therapeutic use*
D007473:Ion Channels; D014700:Verapamil